Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study

Abstract

ObjectiveThe aim of the current study was to assess the relationship between classic cardiovascular risk factors and risk of not only the first recurrent atherosclerotic cardiovascular event, but also the total number of non-fatal and fatal cardiovascular events in patients with recently clinically manifest cardiovascular disease (CVD).DesignProspective cohort study.SettingTertiary care centre.Participants7239 patients with a recent first manifestation of CVD from the prospective UCC-SMART (Utrecht Cardiovascular Cohort - Second Manifestations of ARTerial disease) cohort study.Outcome measuresTotal cardiovascular events, including myocardial infarction, stroke, vascular interventions, major limb events and cardiovascular mortality.ResultsDuring a median follow-up of 8.9 years, 1412 patients had one recurrent cardiovascular event, while 1290 patients had two or more recurrent events, with a total of 5457 cardiovascular events during follow-up. The HRs for the first recurrent event and cumulative event burden using Prentice-Williams-Peterson models, respectively, were 1.36 (95% CI 1.25 to 1.48) and 1.26 (95% CI 1.17 to 1.35) for smoking, 1.14 (95% CI 1.11 to 1.18) and 1.09 (95% CI 1.06 to 1.12) for non-high-density lipoprotein (HDL) cholesterol, and 1.05 (95% CI 1.03 to 1.07) and 1.04 (95% CI 1.03 to 1.06) for systolic blood pressure per 10 mm Hg.ConclusionsIn a cohort of patients with established CVD, systolic blood pressure, non-HDL cholesterol and current smoking are important risk factors for not only the first, but also subsequent recurrent events during follow-up. Recurrent event analysis captures the full cumulative burden of CVD in patients.

Robust inference for causal mediation analysis of recurrent event data

“…For recurrent event data, these methods can be applied to analyze mediation effects on the time to first recurrence. However, as previously noted, subsequent recurrent events following the first one also hold valuable information that should not be disregarded 16‐19 …”

“…However, as previously noted, subsequent recurrent events following the first one also hold valuable information that should not be disregarded. [16][17][18][19]…”

Possible clinical usefulness of polygenic risk scores among patients with established atherosclerotic cardiovascular disease

“…In the study by Groenland et al, the authors replicated the 275 association of a PRS for LDL-C and a PRS for SBP with these risk factors, constructed by 276 SNPs identified through the on-going, single-center, prospective cohort study in the Netherlands [16]. Groenland et al used data from patients enrolled in the Utrecht Cardiovascular Cohort-Second Manifestations of Arterial Disease (UCC-SMART) study [16,17]. The UCC-SMART study is an ongoing, single-center, prospective cohort at the tertiary referral center University Medical Center Utrecht (UMCU) in the Netherlands [17].…”

“…Groenland et al used data from patients enrolled in the Utrecht Cardiovascular Cohort-Second Manifestations of Arterial Disease (UCC-SMART) study [16,17]. The UCC-SMART study is an ongoing, single-center, prospective cohort at the tertiary referral center University Medical Center Utrecht (UMCU) in the Netherlands [17].…”